IDEAYA Biosciences (IDYA) Non-Current Deffered Revenue (2018 - 2025)

IDEAYA Biosciences (IDYA) has 5 years of Non-Current Deffered Revenue data on file, last reported at $1.7 million in Q3 2025.

• For the quarter ending Q3 2025, Non-Current Deffered Revenue changed N/A year-over-year to $1.7 million; the trailing twelve-month figure through Sep 2025 stood at $1.7 million (changed N/A YoY), and the FY2022 full-year result was $5.2 million, down 83.38% from the prior year.
• Non-Current Deffered Revenue declined to $1.7 million in Q3 2025, from $5.2 million in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $52.1 million in Q1 2021 to a low of $1.7 million in Q3 2025.
• A 3-year average of $22.5 million and a median of $10.2 million in 2022 frame the typical range for Non-Current Deffered Revenue.
• Across the five-year window, Non-Current Deffered Revenue decreased 15.02% in 2021 and tumbled 83.38% in 2022, its largest moves.
• Tracing IDYA's Non-Current Deffered Revenue over 3 years: stood at $31.2 million in 2021, then plunged by 83.38% to $5.2 million in 2022, then tumbled by 67.68% to $1.7 million in 2025.
• Business Quant data shows IDYA's Non-Current Deffered Revenue at $1.7 million in Q3 2025, $5.2 million in Q4 2022, and $7.3 million in Q3 2022.